XML 29 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies - Additional Information (Detail)
In Millions, unless otherwise specified
3 Months Ended 39 Months Ended 3 Months Ended 27 Months Ended 3 Months Ended 1 Months Ended
Mar. 31, 2014
Chemport
USD ($)
Mar. 31, 2014
Chemport
USD ($)
Mar. 31, 2014
BASF
USD ($)
Mar. 31, 2014
Slanhmor
USD ($)
Mar. 31, 2014
Slanhmor
USD ($)
Mar. 31, 2014
Amr One Hundred One
Contract
Sep. 30, 2013
Chemport
USD ($)
Jul. 31, 2011
Chemport
USD ($)
Mar. 31, 2014
Chemport
USD ($)
Dec. 31, 2013
Chemport
USD ($)
Dec. 31, 2012
Chemport
Anticipated investment before the end of 2012
USD ($)
Mar. 31, 2014
Chemport
Maximum
USD ($)
Mar. 31, 2014
Further Indication for AMR101
Laxdale Limited
Potential Marketing Approval 1
USD ($)
Mar. 31, 2014
Further Indication for AMR101
Laxdale Limited
Potential Marketing Approval 1
GBP (£)
Mar. 31, 2014
Further Indication for AMR101
Laxdale Limited
Potential Marketing Approval 2
USD ($)
Mar. 31, 2014
Further Indication for AMR101
Laxdale Limited
Potential Marketing Approval 2
GBP (£)
Mar. 31, 2014
Further Indication for AMR101
Laxdale Limited
Maximum
USD ($)
Mar. 31, 2014
Further Indication for AMR101
Laxdale Limited
Maximum
GBP (£)
Mar. 31, 2014
First Indication for AMR101
Laxdale Limited
USD ($)
Mar. 31, 2014
First Indication for AMR101
Laxdale Limited
GBP (£)
Commitments and Contingencies Disclosure [Line Items]                                        
Number of signed agreements           2                            
Payment made under the agreements $ 1.3 $ 3.1 $ 0 $ 0.4 $ 6.2                              
Minority share equity investment commitment                     1.6 3.3                
Cash paid for cost method investment               1.7                        
Investment in supplier sold amount             1.3                          
Carry amount of investment                 2.0 3.3                    
Potential aggregate stock or cash payment                         $ 8.3 £ 5.0 $ 8.3 £ 5.0 $ 16.6 £ 10.0 $ 12.5 £ 7.5